Datopotamab deruxtecan

• Description:

  Datopotamab deruxtecan (DS-1062) is a trophoblast cell surface antigen 2 (TROP2) -targeted antibody-drug conjugate (ADC) with antitumor activity. Datopotamab deruxtecan induces significant antibody-dependent cellular cytotoxicity in the presence of peripheral blood lymphocytes and inhibits tumor growth in xenograft models.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Molecular Formula:

  ——

• Notes:

  Research use only, not for human use.

• Receptor:

  Topoisomerase | Antibody-Drug Conjugates (ADCs)

• CAS Number:

  2238831-60-0